Photograph: Cristina Spano
Jul 17th 2026|3 min read
Few products have captured public interest as fast as GLP-1 receptor-agonist weight-loss drugs. But one unforeseen consequence of their popularity has been to create what is, in effect, one of the biggest off-label medical experiments ever. This is the rapid spread of “microdosing”: in other words, of taking less than the recommended amount.
Climate change
The planet is reflecting less light back into space. That is making the world hotter